MML Investors Services LLC Has $362,000 Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

MML Investors Services LLC lessened its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 20.8% in the third quarter, according to its most recent filing with the SEC. The firm owned 3,815 shares of the company’s stock after selling 1,003 shares during the period. MML Investors Services LLC owned 0.05% of VanEck Pharmaceutical ETF worth $362,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. lifted its position in VanEck Pharmaceutical ETF by 51.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock valued at $23,565,000 after acquiring an additional 84,273 shares in the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of VanEck Pharmaceutical ETF by 33.6% in the third quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock valued at $22,322,000 after purchasing an additional 59,025 shares in the last quarter. Miller Investment Management LP boosted its position in shares of VanEck Pharmaceutical ETF by 13.4% during the third quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock worth $19,722,000 after buying an additional 24,446 shares during the period. Northwestern Mutual Wealth Management Co. boosted its position in shares of VanEck Pharmaceutical ETF by 1.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 160,039 shares of the company’s stock worth $14,641,000 after buying an additional 2,694 shares during the period. Finally, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management bought a new position in shares of VanEck Pharmaceutical ETF during the third quarter worth about $8,743,000.

VanEck Pharmaceutical ETF Stock Performance

NASDAQ PPH opened at $87.70 on Wednesday. VanEck Pharmaceutical ETF has a 52 week low of $80.57 and a 52 week high of $99.51. The stock’s 50 day moving average price is $89.96 and its two-hundred day moving average price is $92.83. The stock has a market capitalization of $648.10 million, a price-to-earnings ratio of 21.04 and a beta of 0.72.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.